Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)HIV Pre-exposure ProphylaxisActive, not recruitingPhase 32026-08-28NCT07047716

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Gilead Sciences180

30 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Be Well Medical CenterBerkleyUnited States9
BIOS Clinical ResearchPalm SpringsUnited States8
Bridge HIV, San Francisco Department of Public HealthSan FranciscoUnited States4
Central Texas Clinical ResearchAustinUnited States13
Children's National HospitalWashington D.C.United States100
Fenway HealthBostonUnited States8
Howard Brown Health CenterChicagoUnited States6
Icahn School of Medicine at Mount Sinai - Clinical and Translational Research CenterNew YorkUnited States1
ICAP at Columbia University- Bronx Prevention CenterThe BronxUnited States2
Johns Hopkins Hospital - Clinical Research UnitBaltimoreUnited States1
Midway Immunology and Research CenterFt. PierceUnited States11
Mills Clinical ResearchLos AngelesUnited States8
NC TraCS Institute - CTRC, University of North Carolina at Chapel HillChapel HillUnited States1
Penn Prevention UnitPhiladelphiaUnited States3
Philadelphia FIGHT Community Health Centers, Jonathan Lax Treatment CenterPhiladelphiaUnited States3
Ruane Clinical Research Group, Inc.Los AngelesUnited States2
St. Jude Children's Research HospitalMemphisUnited States194
The Crofoot Research CenterHoustonUnited States3
The Hope Clinic of Emory UniversityAtlantaUnited States1
The ID Prevention Research UnitMiamiUnited States1
UAB Sexual Health Research ClinicBirminghamUnited States2
UCLA Clinic CareLos AngelesUnited States1
UCLA Vine Street ClinicLos AngelesUnited States2
UCSD AntiViral Research Center (AVRC)San DiegoUnited States3
University Medical CenterNew OrleansUnited States1